Cleveland Clinic researchers discover what drives – and what may halt – virus-induced cancer
Multiple Cleveland Clinic sites to participate in National Cancer Institute trial comparing treatment regimens for newly diagnosed patients
Two thirds of patients responded to CAR T-cell therapy
Cleveland Clinic oncologists’ selected abstracts
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Notable research chosen by Cleveland Clinic Cancer Center staff
Study examines how infiltrative features affect prognosis
Genetics affect how patients respond
Genetic analysis aids classification, therapeutic decisions
More efficient, safer therapy may be on horizon